IMPLANT SITE HYPERTROPHY

IMPLANT SITE HYPERTROPHY was reported 9 times

IMPLANT SITE HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HISTRELIN ACETATE 2 0.0023
1 ETONOGESTREL 3 0.0001
2 NYSTATIN OINTMENT 1 0.0000
3 NYSTATIN CREAM 1 0.0000
4 NYSTATIN 1 0.0000
5 ENALAPRIL 1 0.0000
6 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
7 CYCLOSPORINE 1 0.0000
8 SIMVASTATIN 1 0.0000
9 METOPROLOL TARTRATE 1 0.0000
10 LEVOTHYROXINE SODIUM 1 0.0000